Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent <i>Clostridioides difficile</i> Infection.

Papazyan, Romeo; Ferdyan, Nicky; Srinivasan, Karthik; Gonzalez, Carlos; Shannon, William D; Blount, Ken; Fuchs, Bryan C

Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent Clostridioides difficile Infection.

Papazyan, Romeo; Ferdyan, Nicky; Srinivasan, Karthik; Gonzalez, Carlos; Shannon, William D; Blount, Ken; Fuchs, Bryan C.

Afiliação

Papazyan R; Ferring Research Institute, 4245 Sorrento Valley Blvd, San Diego, CA 92121, USA.
Ferdyan N; Ferring Research Institute, 4245 Sorrento Valley Blvd, San Diego, CA 92121, USA.
Srinivasan K; Ferring Research Institute, 4245 Sorrento Valley Blvd, San Diego, CA 92121, USA.
Gonzalez C; BioRankings, St. Louis, MO 63108, USA.
Shannon WD; BioRankings, St. Louis, MO 63108, USA.
Blount K; Rebiotix Inc., A Ferring Company, Roseville, MN 55113, USA.
Fuchs BC; Ferring Research Institute, 4245 Sorrento Valley Blvd, San Diego, CA 92121, USA.

Microorganisms ; 11(1)2023 Jan 05.

Article em En | MEDLINE | ID: mdl-36677428

Palavras-chave

Clostridioides difficile; RBX2660; bile acids; dysbiosis; microbiota-based investigational therapeutic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article